SEC Form 4 · accession 0001209191-16-156424
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Schimmel
Director
Period of report
Dec 20, 2016
Accepted (ET)
Dec 22, 2016 · 11:53 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 20, 2016 | P | 15,000 | $2.274 | A | 711,814 | I | See Footnote |
| Common StockF1 | Dec 21, 2016 | P | 10,000 | $2.2818 | A | 721,814 | I | See Footnote |
| Common Stock | holding | — | — | — | 40,440 | D | ||
| Common StockF2 | holding | — | — | — | 283,581 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/20.
- F2These shares are owned directly by Paul R. Schimmel Prototype PSP. The Reporting Person is the trustee of the Paul R. Schimmel Prototype PSP.